8th Annual Life Science Strengthening Patient Advocacy Engagement Conference

July 30-31, 2019 | Philadelphia, PA
Four Points by Sheraton Philadelphia City Center
Download Agenda


“I thought the conference was excellent!  Having a conference tailored to one discipline made each panel and contact relevant.”

Director, Compliance & Legal Affairs

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead

About the Conference:

Pharmaceutical corporations throughout the industry look forward to the Q1 Strategic Patient Advocacy Engagement program as a forum for benchmarking current advocacy platforms, sharing challenges as well as thoughtful problem solving to the hurdles faced by corporations and advocacy groups in ensuring access for all patients. As patient advocacy continues to evolve and become increasingly sophisticated, there is a need for alignment with overall corporate goals to drive forward the value of engagement and support of patient populations from the top down.

Topics to Be Addressed:

  • Renewed focus on creating a compliant advocacy framework
  • Balancing advocacy goals against corporate commercial targets
  • Perspectives on advocacy vs. patient services or patient assistance
  • Effective patient engagement where disease groups do not exist
  • Ultimately ensuring the right access at the right time to help patients

Program Highlights:

  • Immersive group discussions for robust educational delivery
  • Various perspectives from industry, advocacy groups & FDA
  • Industry leadership delivering masterclass style presentations


75 Attendees

All attendees come directly from life science companies

Distinguished Presenters

28 Speakers


Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This